Last update: Dec. 8, 2017


Low Risk for breastfeeding

Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

Intestinal, biliary and genitourinary antispasmodic with few bibliographical references.

Since the last update, we have not found published data on its excretion in breast milk.

According to the manufacturer, adverse reactions are very rare and mild (Atlantis 2003).

Its use is authorized in small infants (Atlantis 2003).

Until there is more published data on this drug in relation to breastfeeding, safer known alternatives may be preferable, especially during the neonatal period and in case of prematurity.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Phloroglucinol is also known as

Phloroglucinol in other languages or writings:


Main tradenames from several countries containing Phloroglucinol in its composition:


Variable Value Unit
Oral Bioavail. 100 %
Molecular weight 126 daltons
VD 3,3 l/Kg
Tmax 0,9 hours
T1/2 6 - 8 hours


  1. Atlantis. Floroglucinol. Ficha técnica. 2003 Full text (in our servers)
  2. Atlantis. Floroglucinol. Ficha técnica pediátrica. 2002 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by IHAN from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM